Clinical trial
Phase 1 Safety and Pharmacokinetic Study of AI-700 in Patients With Diminished…
NCT00156780 · Acusphere, Industry · Completed
Key facts
| NCT number | NCT00156780 |
|---|---|
| Title | Phase 1 Safety and Pharmacokinetic Study of AI-700 in Patients With Diminished DLCO and COPD and/or CHF |
| Official title | A Phase 1, Double Blind, Crossover, Placebo-Controlled, Dual-Injection, Safety and Pharmacokinetic Study of AI-700 in Patients With Diminished DLCO and Chronic Obstructive Pulmonary Disease (COPD) and/or Congestive Heart Failure (CHF) |
| Lead sponsor | Acusphere, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Congestive Heart Failure, Chronic Obstructive Pulmonary Disease |
| Intervention type | Drug |
| Interventions | AI-700 |
| Start date | Aug 1, 2004 |
| Completion | Jul 1, 2005 |
| First posted | Sep 12, 2005 |
| Last update posted | Oct 23, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: